Spearhead Capital Advisors, LLC Beam Therapeutics Inc. Transaction History

Spearhead Capital Advisors, LLC

  • $92.3 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022
SELL
$53.73 - $82.16 $192,622 - $294,543
-3,585 Closed
0 $0
Q4 2021

Jan 25, 2022
BUY
$68.02 - $99.06 $2,244 - $3,268
33 Added 0.93%
3,585 $286,000
Q3 2021

Oct 27, 2021
SELL
$84.37 - $133.6 $13,499 - $21,376
-160 Reduced 4.31%
3,552 $309,000
Q2 2021

Aug 10, 2021
BUY
$64.12 - $128.71 $238,013 - $477,771
3,712 New
3,712 $478,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Spearhead Capital Advisors, LLC Portfolio

Follow Spearhead Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email